Review
Open access
Sep 2026
Artificial Intelligence Algorithms for Early Detection and Risk Stratification of Type 2 Diabetes Mellitus, Multimodal Bioinformatic Phenotyping, and Its Complications: A Technical Review of Classical Machine Learning, Deep Learning, and Post-Hoc Feature Attribution
Overall, AI stands out as a viable and scalable complement to conventional screening, although gaps remain in multicentre prospective validation, reporting standardisation, and algorithmic equity across populations.
Kattia Orozco-Romero, Jonas Pariona-Torres, Jose Cornejo
· Bioengineering · 0 citations